STOCK TITAN

Celldex to Present at the 2022 Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Celldex Therapeutics (NASDAQ:CLDX) announced that its senior management will participate in a fireside chat at the 2022 Jefferies Global Healthcare Conference on June 8, 2022, at 8:30 a.m. ET in New York City. This event will provide insights into the company's advancements in monoclonal and bispecific antibodies aimed at treating severe diseases.

A webcast of the presentation will be accessible on the Investors & Media section of the Celldex website, with a replay available for 30 days afterward.

Positive
  • None.
Negative
  • None.

HAMPTON, N.J., June 06, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a fireside chat at the 2022 Jefferies Global Healthcare Conference in New York City on Wednesday, June 8, 2022 at 8:30 a.m. ET.

A webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for 30 days following the event.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Senior Director, Investor Relations & Corporate Communications
(484) 788-8560
ptill@celldex.com


FAQ

When will Celldex Therapeutics participate in the Jefferies Global Healthcare Conference?

Celldex Therapeutics will participate in the Jefferies Global Healthcare Conference on June 8, 2022, at 8:30 a.m. ET.

How can I watch the Celldex Therapeutics presentation at the conference?

You can watch the Celldex Therapeutics presentation via a webcast available on the Investors & Media section of their website.

What is the main focus of Celldex Therapeutics?

Celldex Therapeutics is focused on developing monoclonal and bispecific antibodies for treating various severe diseases, including cancers and inflammatory conditions.

Will the Celldex Therapeutics presentation be available after the event?

Yes, a replay of the Celldex Therapeutics presentation will be available for 30 days following the event.

Celldex Therapeutics, Inc

NASDAQ:CLDX

CLDX Rankings

CLDX Latest News

CLDX Stock Data

1.76B
66.12M
0.3%
110.11%
11.02%
Biotechnology
In Vitro & in Vivo Diagnostic Substances
Link
United States of America
HAMPTON